Comparing access to orphan medicinal products in Europe

被引：0
|
作者：
Bernarda Zamora
Francois Maignen
Phill O’Neill
Jorge Mestre-Ferrandiz
Martina Garau
机构：
[1] Office of Health Economics,
来源：
Orphanet Journal of Rare Diseases | / 14卷
关键词：
Orphan drugs; Access; HTA; Reimbursement;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years' multi-stakeholder dialogue on improving access in Europe via MoCA
    Cavaller-Bellaubi, Maria
    Hughes-Wilson, Wills
    Kubinova, Sarka
    Van de Casteele, Marc
    Van Lente, Evert Jan
    Degortes, Emanuele
    Ponten, Johan
    Eichler, Hans-Georg
    Le Cam, Yann
    Boselli, Simone
    Bucsics, Anna
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [22] Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years’ multi-stakeholder dialogue on improving access in Europe via MoCA
    Maria Cavaller-Bellaubi
    Wills Hughes-Wilson
    Šárka Kubinová
    Marc Van de Casteele
    Evert Jan Van Lente
    Emanuele Degortes
    Johan Pontén
    Hans-Georg Eichler
    Yann Le Cam
    Simone Boselli
    Anna Bucsics
    Orphanet Journal of Rare Diseases, 18
  • [23] Registration of new medicinal products in Europe
    Singer, Ernst
    ONKOLOGIE, 2008, 31 : 64 - 66
  • [24] Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
    Pijeira Perez, Yankier
    Wood, Eifiona
    Hughes, Dyfrig A.
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [25] Establishment of a value assessment framework for orphan medicinal products in China
    Chen, Handong
    Xiang, Yuliang
    Tang, Xian
    Hu, Ming
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [26] Clinical evidence for orphan medicinal products-a cause for concern?
    Eline Picavet
    David Cassiman
    Carla E Hollak
    Johan A Maertens
    Steven Simoens
    Orphanet Journal of Rare Diseases, 8
  • [27] Determinants for successful marketing authorisation of orphan medicinal products in the EU
    Putzeist, Michelle
    Heemstra, Harald E.
    Garcia, Jordi Llinares
    Mantel-Teeuwisse, Aukje K.
    Gispen-De Wied, Christine C.
    Hoes, Arno W.
    Leufkens, Hubert G. M.
    DRUG DISCOVERY TODAY, 2012, 17 (7-8) : 352 - 358
  • [28] Clinical evidence for orphan medicinal products-a cause for concern?
    Picavet, Eline
    Cassiman, David
    Hollak, Carla E.
    Maertens, Johan A.
    Simoens, Steven
    ORPHANET JOURNAL OF RARE DISEASES, 2013, 8
  • [29] Costs of orphan medicinal products: longitudinal analysis of expenditure in Wales
    Yankier Pijeira Perez
    Eifiona Wood
    Dyfrig A Hughes
    Orphanet Journal of Rare Diseases, 18
  • [30] Funding orphan medicinal products beyond price: sustaining an ecosystem
    de Sola-Morales, Oriol
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2019, 20 (09): : 1283 - 1286
12345